BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,065 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $59,039 | -31.0% | 1,765 | -11.9% | 0.01% | -35.0% |
Q1 2024 | $85,608 | -7.7% | 2,003 | -16.5% | 0.02% | -13.0% |
Q4 2023 | $92,784 | -3.8% | 2,400 | -6.1% | 0.02% | -14.8% |
Q3 2023 | $96,426 | -17.2% | 2,555 | 0.0% | 0.03% | -20.6% |
Q2 2023 | $116,406 | +12.3% | 2,555 | 0.0% | 0.03% | +13.3% |
Q1 2023 | $103,631 | +70880.1% | 2,555 | -10.5% | 0.03% | -36.2% |
Q4 2022 | $146 | -99.9% | 2,855 | -3.4% | 0.05% | -14.5% |
Q3 2022 | $159,000 | -36.7% | 2,955 | -24.3% | 0.06% | -32.1% |
Q2 2022 | $251,000 | -17.2% | 3,905 | 0.0% | 0.08% | -3.6% |
Q1 2022 | $303,000 | -19.4% | 3,905 | -10.7% | 0.08% | -20.0% |
Q4 2021 | $376,000 | +1.3% | 4,375 | -5.1% | 0.10% | -7.1% |
Q3 2021 | $371,000 | 0.0% | 4,612 | 0.0% | 0.11% | 0.0% |
Q2 2021 | $371,000 | +2082.4% | 4,612 | +2206.0% | 0.11% | +2160.0% |
Q1 2021 | $17,000 | +6.2% | 200 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $16,000 | 0.0% | 200 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $16,000 | -55.6% | 200 | -52.8% | 0.01% | -45.5% |
Q2 2020 | $36,000 | +5.9% | 424 | 0.0% | 0.01% | -26.7% |
Q1 2020 | $34,000 | -2.9% | 424 | 0.0% | 0.02% | +7.1% |
Q4 2019 | $35,000 | +94.4% | 424 | +112.0% | 0.01% | +40.0% |
Q3 2019 | $18,000 | +12.5% | 200 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $16,000 | 0.0% | 200 | 0.0% | 0.01% | -9.1% |
Q1 2019 | $16,000 | +23.1% | 200 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $13,000 | – | 200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |